Improving survival in aggressive childhood cancers

 

A new drug combination could help improve survival and quality of life for some children with a particularly aggressive form of brain tumour,...

Childhood cancer: Molecular super-enhancers determine progression of neuroblastomas

 

Childhood neuroblastomas display extreme differences in the way they develop: they can shrink spontaneously or spread aggressively to healthy tissue....

Personalized drug screens could guide treatment for children with brain cancer

 

Scientists at Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego School of Medicine and Hopp Children’s Cancer...

Which treatment is best for childhood brain tumors? Global trial receives funding of EUR 2.2m

 

The German Childhood Cancer Foundation (Deutsche Kinderkrebsstiftung, DKS) is providing EUR 2.2m to fund the first phase III clinical trial to...

September – International Childhood Cancer Awareness Month: New hope for cancer relapse cases

 

Around 2,000 children in Germany are diagnosed with cancer every year. The chances of recovery are now good, but if the cancer comes back, the...

Gene defect influences tumor development in childhood brain tumors

 

Medulloblastoma are the most common malignant brain tumors affecting children. The greatest danger is that the cancer cells can quickly spread to the...

Pan-European registry study shows benefits of cancer genome sequencing for children with cancer

 

In some cases, cancer genome analysis can help find a suitable therapy for children with relapsed cancer and delay the progression of the disease....

New cell culture test to assess drugs against childhood brain tumors

 

Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a test system that measures the...

Coronavirus: Information for families with children with cancer

 

The physicians of the Pediatric Oncology provide information for parents and relatives whose children are receiving or have had cancer treatment....

Award for INFORM clinical trial

 

In many cases, when cancer comes back in children, there are no treatment options left. Through the INFORM study at the Hopp Children’s Cancer Center...